Glycolaldehyde-modified proteins cause adverse functional and structural aortic remodeling leading to cardiac

Sibren Haesen1, Ümare Cöl1, Wouter Schurgers1

  • 1Biomedical Research Institute (BIOMED), Hasselt University, Martelarenlaan 42, 3500, Hasselt, Belgium.

Scientific Reports
|July 24, 2020
PubMed

Insights

High-molecular-weight advanced glycation end products (HMW-AGEs) from diet harm blood vessel function and structure. Chronic exposure leads to vascular remodeling, oxidative stress, and increased risk of cardiovascular diseases (CVDs).

Area of Science:

  • Biochemistry
  • Cardiovascular Science
  • Pathology

Background:

  • Advanced glycation end products (AGEs) are implicated in diabetic vascular complications and cardiovascular diseases (CVDs).
  • High-molecular-weight AGEs (HMW-AGEs), prevalent in Western diets, have been shown to impair cardiac function.
  • The specific impact of HMW-AGEs on vascular function and structure remained largely unknown.

Purpose of the Study:

  • To investigate the effects of chronic exposure to HMW-AGEs on vascular function and structure in a rat model.
  • To determine if HMW-AGEs contribute to vascular remodeling and oxidative stress.

Main Methods:

  • Adult male Sprague Dawley rats received daily injections of HMW-AGEs or a control solution for six weeks.
  • Vascular function was assessed by measuring aortic ring contraction and relaxation responses.
  • Vascular structure was evaluated by analyzing collagen deposition and intima-media thickness.

Main Results:

  • HMW-AGEs exposure led to intracardiac pressure overload, evidenced by increased systolic and mean pressures.
  • Aortic rings from HMW-AGEs-treated rats showed enhanced contraction to phenylephrine (PE) and impaired relaxation to acetylcholine (ACh), but not SNP.
  • Reduced plasma cyclic GMP levels, increased collagen deposition, and thickened intima-media were observed in HMW-AGEs animals.
  • Superoxide dismutase (SOD) administration restored ACh-induced relaxation and reduced the effective dose (EC50).

Conclusions:

  • Chronic HMW-AGEs exposure induces adverse vascular remodeling, characterized by disturbed vasomotor function.
  • Increased oxidative stress and structural changes in the aorta contribute to HMW-AGEs-induced vascular dysfunction.
  • HMW-AGEs play a significant role in the development of cardiovascular diseases (CVDs).

Related Concept Videos

Aortic Regurgitation I: Introduction01:15

Aortic Regurgitation I: Introduction

IntroductionAortic regurgitation is characterized by the backward flow of blood from the aorta into the left ventricle during diastole and arises from the improper closure of the aortic valve. This condition results in left ventricular volume overload and can stem from both acute and chronic etiologies, each contributing uniquely to the disease's progression and symptomatology.Acute and Chronic CausesAcute aortic regurgitation often results from events that suddenly impair the integrity of the...
300
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
557
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.5K
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
771
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
2.1K